INTERNATIONAL STRATEGIC HEALTHCARE COMMUNICATIONS

Experienced, trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, digital health, biotech and healthcare services, large & small.

WHAT WE DO

COMMUNICATING A COMPELLING GROWTH STORY TO THE INVESTMENT COMMUNITY

Effectively communicating a company’s strategy, growth ambitions, and the reasons to “invest now” is critical for management teams as they seek to build investor confidence and support. We have an exceptional track record in advising globally on healthcare fund raisings, IPOs and M&A transactions.

FIND OUT MORE

Insights & Latest News

Dirk Beher, CEO: "#PSP is a rare neurological condition for which there is currently no treatment available. ASN120290 is an #orally bioavailable molecule that has the potential of treating the root cause of the #neurodegeneration."

#FDA grants orphan drug designation to treatment of progressive supranuclear palsy https://t.co/IRZoLu1yWM @US_FDA @EPM_Magazine #Asceneuron #PSP

Bio€quity Europe

14th-16th May 2018, Ghent, Belgium

Anglo-Nordic Life Science Investor Conference

24th May 2018, London, UK

MEET US THERE

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH